Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital

Journal of Intensive Care Medicine
Sandeep KodityalLawrence Rice

Abstract

Heparin-induced thrombocytopenia requires immediate alternative anticoagulation to prevent or treat thromboembolic complications. Argatroban was approved based on multiple-center studies from the 1990s, but subsequent changes in prevailing awareness, diagnostic testing and therapeutic strategies for heparin-induced thrombocytopenia might affect results of argatroban therapy. Charts were retrospectively reviewed from patients administered argatroban for suspected heparin-induced thrombocytopenia over 22 months at a single large university hospital. Twenty-seven patients, most in intensive care units, received a median 0.5 microg/kg/min argatroban over a median 5.5 days. Patients had isolated heparin-induced thrombocytopenia (n = 10), had heparin-induced thrombocytopenia with thrombosis (n = 9), or lacked active heparin-induced thrombocytopenia (n = 8) on final analysis. New thromboses (14.8%), progression of preexisting thromboses (0%), amputation secondary to heparin-induced thrombocytopenia (0%), death (22.2%), bleeding requiring transfusion (3.7%), and any bleeding (22.2%) compared favorably with older multiple-center reports. Deaths occurred mainly with preexisting multiple-organ failure. In contemporary "real world" use, ar...Continue Reading

References

Apr 1, 1984·Annals of Internal Medicine·D J King, J G Kelton
Nov 1, 1996·The American Journal of Medicine·T E Warkentin, J G Kelton
Jan 1, 1997·Seminars in Thrombosis and Hemostasis·M J HurstingR P Schwarz
Jun 23, 1999·The American Journal of Medicine·D E WallisJ F Moran
Apr 11, 2001·Circulation·B E LewisUNKNOWN ARG-911 Study Investigators
Apr 24, 2003·The Annals of Pharmacotherapy·Marc G ReichertSylvia Y Dolinski
Aug 2, 2003·European Journal of Haematology·Sandeep KodityalLawrence Rice
Aug 13, 2003·Archives of Internal Medicine·Bruce E LewisUNKNOWN Argatroban-915 Investigators
Jan 14, 2004·Archives of Internal Medicine·Abhay F SrinivasanKelty R Baker
Feb 26, 2004·Archives of Internal Medicine·Jack HirshJohn G Kelton
Mar 26, 2004·Pharmacotherapy·David R WilliamsonGeneviève Grégoire
Jul 31, 2004·Seminars in Thoracic and Cardiovascular Surgery. Pediatric Cardiac Surgery Annual·Bahaaldin AlsoufiRoss Ungerleider
May 24, 2005·Thrombosis Research·William H MatthaiJohn G Kelton

❮ Previous
Next ❯

Citations

Nov 15, 2006·Journal of Thrombosis and Thrombolysis·Louis M GuzziMarcie J Hursting
Dec 6, 2008·Journal of Cardiovascular Pharmacology·Marcie J Hursting, Catherine N Verme-Gibboney
Sep 23, 2010·Vascular Health and Risk Management·Luciano Babuin, Vittorio Pengo
Jun 19, 2007·Drugs & Aging·John R BartholomewMarcie J Hursting
Aug 7, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Sohita Dhillon
Oct 18, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jens LutzKlaus Thürmel
May 1, 2008·Expert Review of Clinical Pharmacology·Lawrence Rice, Marcie J Hursting
Apr 3, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marcie J Hursting, Joseph Soffer
Mar 27, 2007·Pharmacotherapy·William E DagerMaureen A Smythe
Apr 17, 2015·Journal of Cardiothoracic Surgery·Se-Chan KimGeorg Baumgarten
Feb 24, 2015·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Fahad A S Al-Eidan
Aug 15, 2008·Journal of Intensive Care Medicine·Susan M BegelmanJohn R Bartholomew
Nov 26, 2008·Foot & Ankle International·Christopher W DiGiovanni
Feb 28, 2008·The Annals of Pharmacotherapy·William D HoffmanMarcie J Hursting
Nov 25, 2006·Hematology·Theodore E Warkentin
Apr 16, 2021·American Journal of Hematology·Henning NiliusMichael Nagler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Anthony GrayBruce E Lewis
© 2021 Meta ULC. All rights reserved